COMMUNIQUÉS West-GlobeNewswire

Novo Nordisk A/S - Share repurchase programme
29/05/2019
Bagsværd, Denmark, 29 May 2019 - On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Fluidigm Introduces Advanta RNA Fusions NGS Library Prep Assay to Accelerate Translational and Clinical Cancer Research
29/05/2019
Introducing the most comprehensive commercially available NGS assay for detecting gene fusions in cancer using an automated nanoscale library prep workflow SOUTH SAN FRANCISCO, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- [...]
Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and Renews Research with Yost Group
29/05/2019
The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies [...]
Assure Holdings Reports First Quarter 2019 Financial Results
29/05/2019
– Q1 2019 Managed Case Volume Increased 97% to 1,184 – DENVER, May 29, 2019 (GLOBE NEWSWIRE) -- Assure Holdings Corp. (the “Company” or “Assure”) (TSXV: IOM; OTCQB: ARHH), a provider of intraoperative neuromonitoring [...]
Allogene Therapeutics Announces June 2019 Investor Conference Schedule
29/05/2019
SOUTH SAN FRANCISCO, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Allogene Therapeutics, Inc. (Nasdaq: ALLO), a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) therapies for [...]
AIT Therapeutics Announces Study Published in Journal of Cystic Fibrosis
29/05/2019
GARDEN CITY, N.Y. and REHOVOT, Israel, May 29, 2019 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (NASDAQ: AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO [...]
PDS Biotechnology Signs Cooperative Research and Development Agreement with National Cancer Institute to Perform a Phase 2 Clinical Study of PDS0101 in Combination with Other Immune-modulating Agents in Advanced HPV-related Cancers
29/05/2019
BERKELEY HEIGHTS, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (“PDS Biotechnology”) (Nasdaq: PDSB), a clinical-stage immuno-oncology company pioneering the development of novel multifunctional [...]
Coverage Initiated for Endonovo Therapeutics via NetworkNewsWire
29/05/2019
NEW YORK, May 29, 2019 (GLOBE NEWSWIRE) -- via NetworkWire -- Endonovo Therapeutics (OTCQB: ENDV), an innovative biotechnology company developing a bioelectronic approach to regenerative medicine, today announces it has [...]
Anchiano Therapeutics Announces Appointment of Salar Roshan as Head of Business Development
29/05/2019
CAMBRIDGE, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”), a pivotal-stage biopharmaceutical company focused on the discovery and development of novel therapies [...]
Minerva Neurosciences to Present at Jefferies 2019 Global Healthcare Conference on June 4, 2019
29/05/2019
WALTHAM, Mass., May 29, 2019 (GLOBE NEWSWIRE) -- Minerva Neurosciences, Inc. (NASDAQ: NERV), a clinical-stage biopharmaceutical company focused on the development of innovative therapies to treat central nervous system [...]
American Cannabis Company, Inc. Announces Strategic Partnership With American Leaf & Joint Submission of Retail Dispensary Application in Massachusetts
29/05/2019
DENVER, CO, May 29, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- American Cannabis Company, Inc. (OTCQB: AMMJ) (“ACC”), a full-service business-to-business cannabis and hemp consulting solutions provider, wishes to [...]
Pascal Biosciences to Present at 2019 BIO International Convention
29/05/2019
Vancouver, BRITISH COLUMBIA and SEATTLE, May 29, 2019 (GLOBE NEWSWIRE) -- Pascal Biosciences Inc. (TSX.V:PAS) (“Pascal” or the “Company”), a drug discovery and development company, today announced the Company will [...]
Fluidigm Introduces Automated Advanta Solid Tumor NGS Library Prep Assay Using Microfluidics Technology
29/05/2019
The first commercially available targeted NGS assay that enables simultaneous detection of somatic variants across 53 solid tumor genes using a highly efficient microfluidic library prep workflow SOUTH SAN FRANCISCO, [...]
Menlo Therapeutics to Present at Upcoming Investor Conferences
29/05/2019
REDWOOD CITY, Calif., May 29, 2019 (GLOBE NEWSWIRE) -- Menlo Therapeutics Inc. (NASDAQ: MNLO), a late-stage biopharmaceutical company focused on the development of serlopitant for the treatment of pruritus (itch), today [...]
Passage Bio to Present at Jefferies 2019 Healthcare Conference
29/05/2019
PHILADELPHIA, May 29, 2019 (GLOBE NEWSWIRE) -- Passage Bio, a genetic medicines company developing AAV-delivered therapeutics for the treatment of rare monogenic central nervous system diseases, today announced that [...]
BBS to present at Småbolagsdagen in Stockholm
29/05/2019
BBS – Bioactive Bone Substitutes, an innovator in orthobiologics, today announced that the company’s Chief Commercial Officer (CCO) Paul Watkins will present the company at Småbolagsdagen in Stockholm on June 3, 2019. [...]
Daré Bioscience to Present at the 2019 BIO International Convention
29/05/2019
SAN DIEGO, May 29, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE), a leader in women’s health innovation, today announced that Sabrina Johnson, President and Chief Executive Officer, will present at the [...]
Fibrocell Receives FDA Regenerative Medicine Advanced Therapy Designation for FCX-007 Gene Therapy for the Treatment of RDEB
29/05/2019
EXTON, Pa., May 29, 2019 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (Nasdaq: FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]
Immunomedics to Participate in Upcoming Healthcare Conferences
29/05/2019
MORRIS PLAINS, N.J., May 29, 2019 (GLOBE NEWSWIRE) -- Immunomedics, Inc. , (NASDAQ: IMMU) (“Immunomedics” or the “Company”), a leading biopharmaceutical company in the area of antibody-drug conjugates (ADC), today [...]

Pages